CDC: Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected RFA-PS-23-003
Sponsor: CDCInternal Deadline: 02/16/2023Institutional Submission Limit: 1Sponsor Deadline: 03/17/2023Program Website
CDC: Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected RFA-PS-23-003This Funding Opportunity Announcement (FOA)... support[s] formative research on
acceptance and perceived barriers and facilitators of using current and future long-acting
antiretroviral therapies among cis-gender Black women with HIV
USC may submit only one application in response to this solicitation.
Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send an updated NIH formatted biosketch (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-073.html) and a two page abstract via email to Richard White (whitejrw@mailbox.sc.edu) by Feb 16, 2023.
CDC indicates that a letter of intent IS NOT REQUIRED and a full application is due by March 17, 2023 .
For more information: https://www.grants.gov/web/grants/view-opportunity.html?oppId=343368